By proceeding, you agree to our Terms of Use and Privacy Policy.
The 13th Annual World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event - and it’s back bigger and better than before! With the recent approval of Astrazeneca and Daiichi Sankyo’s DESTINY-Breast04, supporting Enhertu's use in HER2-low breast cancer as a new therapeutically targetable category, the
Witness discussions, sessions and workshops on ADC development.
Explore new payloads with new mechanisms of action, new linker-payload combinations as well as non-traditional ADCs.
Deep-dive into early process development challenges, overcoming the analytical bottleneck and ensuring the drug product quality.
Learn from experienced peers on scale-up, assay validation and important QA & QC reporting requirements for later clinical and commercial ADC manufacturing.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Catalent is a global leader in providing integrated services, superior delivery technologies, and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics, and consumer health products
Merck Life Sciences is a leader in biomarker immunoassays, including 200+ MILLIPLEX® multiplex kits with over 1,200 different analytes, for use with Luminex® instrumentation, an ultra-high sensitivity platform for Single Molecule Counting (SMC™), inc
ILC Dover is a world leader in the innovative design and production of engineered products employing high-performance flexible materials. Since 1947, the company has provided engineered solutions to complex customer problems.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US.
At Lonza, we enable #AHealthierWorld by supporting our healthcare customers on the path to commercialization.
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services f
BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.
Heraeus, the technology group headquartered in Hanau, Germany, is a leading international family-owned portfolio company. The company’s roots go back to a family pharmacy started in 1660.
Novasep is a leading provider of services in the field of molecule production and purification for the life science industries, based on an unrivalled pool of specialized and differentiating technologies, and on fully committed teams.
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle.
Formed in 2015, PROVEO is now a Division of Cerbios- Pharma SA focused on complete supply chain solution for Antibody Drug Conjugates (ADCs).
Antibody Screening - Unravelling the full potential of entire immune repertoires (millions of B cells) VERAXA´s unique platform can combine the assessment of antibody binding with its functional capabilities in 1 single screening step, using a propri
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.